42 Stocks Moving In Thursday's Mid-Day Session

Gainers

• Applied DNA Sciences, Inc. APDN jumped 53.4% to $13.64 after the company announced it has received FDA emergency use authorization for its coronavirus diagnostic assay kit.
• BioPharmX Corporation BPMX shares jumped 38.2% to $0.659 after the company reported approval of merger with Timber Pharma by shareholders.
• Glory Star New Media Group Holdings Limited GSMG rose 28.3% to $3.1314.
• Allogene Therapeutics Inc ALLO gained 28.2% to $39.71 after the company announced the release of an abstract for its upcoming ASCO meeting presentation, showing data from its Phase 1 dose escalation study of ALLO-501 in relapsed/refractory non-Hodgkin lymphoma.
• Armstrong Flooring, Inc. AFI climbed 26.9% to $2.88. Nomura Instinet upgraded Armstrong Flooring from Neutral to Buy and raised the price target from $2 to $5.
• DiaMedica Therapeutics Inc. DMAC rose 25.2% to $4.72 after the company reported Q1 results and disclosed that DM199 met primary safety and tolerability endpoints in ReMEDy study top-line data.
• Akers Biosciences, Inc. AKER gained 23.2% to $4.35.
• Innovative Solutions and Support, Inc. ISSC surged 21.4% to $5.00 after reporting Q2 results.
• AIM ImmunoTech Inc. AIM rose 18.3% to $2.78 after the company received FDA approval for the first human ampligen trial in coronavirus patients with cancer. The company also reported Q1 results.
• FTS International, Inc. FTSI gained 15.4% to $4.13.
• eMagin Corporation EMAN rose 15.3% to $0.6339 after dropping over 21% on Wednesday.
• Altimmune, Inc. ALT gained 14.7% to $4.74 after reporting upbeat quarterly results.
• ACM Research, Inc. ACMR rose 14.4% to $57.54.
• Pluristem Therapeutics Inc. PSTI gained 14.6% to $10.53. Pluristem provided 28-day follow up for ventilator-dependent COVID-19 patients under compassionate use program in Israel and U.S.
• Bluegreen Vacations Corporation BXG climbed 14.6% to $4.07.
• Cellectis S.A. CLLS shares rose 14.4% to $15.67 after declining around 9% on Wednesday.
• Riot Blockchain, Inc. RIOT rose 13.8% to $2.15 after surging 18% on Wednesday.
• Genetic Technologies Limited GENE gained 13.7% to $2.40.
• The Children's Place, Inc. PLCE jumped 13.2% to $31.80.
• Laureate Education, Inc. LAUR rose 12.2% to $8.60.
• Atomera Incorporated ATOM gained 12% to $6.83.
• Immunic, Inc. IMUX rose 10.9% to $11.29 after the company reported it received first regulatory approval from German Health Authority BfArM to initiated a Phase 2 clinical trial of its selective oral DHODH inhibitor, IMU-838, in COVID-19 patients.
• Futu Holdings Limited FUTU rose 10.8% to $13.61 after reporting Q1 results.
• Revolve Group, Inc. RVLV shares rose 6.7% to $15.62 after the company reported better-than-expected Q1 results.
• Cisco Systems, Inc. CSCO rose 5.1% to $44.07 after the company reported better-than-expected earnings and sales for its third quarter and issued strong earnings outlook for the current quarter.

Check out these big penny stock gainers and losers

Losers

• CytomX Therapeutics, Inc. CTMX shares dipped 34.1% to $9.51 after the company highlighted details of presentations at the ASCO.
• Comstock Resources, Inc. CRK fell 26.5% to $4.78 after the company reported the commencement of a 40 million share common stock offering.
• Virtusa Corporation VRTU dropped 26.4% to $23.38 after the company reported worse-than-expected Q4 results. William Blair downgraded Virtusa from Outperform to Market Perform.
• J. C. Penney Company, Inc. JCP fell 16% to $0.1872 after gaining 12% on Wednesday.
• United Natural Foods, Inc. UNFI fell 15.5% to $19.06.
• Compugen Ltd. CGEN dropped 15.4% to $11.79.
• Arvinas, Inc. ARVN dipped 14.7% to $43.52. Arvinas highlighted that it will present updated Phase 1 data showing clinical activity of PROTAC ARV-110 in patients with refractory prostate cancer at the ASCO.
• Genasys Inc. GNSS fell 13% to $4.07.
• Arcadia Biosciences, Inc.. RKDA fell 12.3% to $4.22 after reporting Q1 results.
• Enochian Biosciences Inc. ENOB dipped 10.8% to $3.79.
• Trillium Therapeutics Inc. TRIL fell 10.7% to $5.75.
• Arcus Biosciences, Inc. RCUS tumbled 10.6% to $27.74.
• Scorpio Tankers Inc. STNG dropped 10.4% to $16.75.
• Babcock & Wilcox Enterprises, Inc. BW shares declined 10.3% to $1.82.
• MacroGenics, Inc. MGNX shares fell 10% to $23.86. MacroGenics will present preliminary clinical results from MGD013 and MGC018 at the ASCO.
• Remark Holdings, Inc. MARK shares fell 8.5% to $1.59. Remark Holdings will review financial results for the fiscal year on Thursday, May 28, 2020.
• Forward Pharma A/S FWP dropped 8.2% to $6.66.